All USA & Canada articles – Page 2
-
NewsCan the ‘good’ bacteria in your mouth act as probiotic cavity fighters?
Discovery of clumping molecules made by gene clusters in the oral microbiome may lead to ways to reengineer the microbes in plaque, a new study shows.
-
NewsCan a healthy gut microbiome help prevent childhood stunting?
Researchers find gut microbiome turnover in children is linked to poor growth outcomes, pointing to microbiome-based diagnostics for malnutrition.
-
NewsGiving food waste fermentation a ‘jolt’ increases chemical production
Adding an electrical jolt to fermentation of industrial food waste speeds up the process and increases the yield of platform chemicals that are valuable components in a wide range of products, new research shows.
-
NewsOcean warming puts vital marine microbe Prochlorococcus at risk
A new study finds that Prochlorococcus prefers ocean water between 66 and 86 degrees and doesn’t tolerate water much warmer. Climate models predict that subtropical and tropical ocean temperatures will exceed that threshold in the next 75 years.
-
NewsCoral-inspired pill offers a new window into the hidden world of the gut
Marine corals have evolved intricate, porous structures that shelter diverse microbial communities. Researchers have borrowed this biological blueprint to create an ingestible pill that can sample bacteria from one of the most inaccessible regions of the human body: the small intestine.
-
NewsStudy shows not all dietary proteins are digested the same way
As protein-rich diets become increasingly popular, a new study suggests that categorizing dietary proteins as either animal- or plant-based fails to effectively capture the source-specific differences in their composition, digestive efficiency and accessibility to the gut microbiota.
-
NewsNew antibiotic to fight superbug C. diff proves effective in clinical trial
As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile wanes, a research team is seeing positive results of a new antibiotic on the scene – ibezapolstat – which is proving successful in fighting these infectious bacteria in clinical trials.
-
NewsResearchers map key human proteins that power coronavirus replication, pointing to new treatment strategies
Scientists have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle, from entering a cell to replicating and releasing new viral particles.
-
NewsIn extensive sequencing study, scientists find few links between cancer and microbiome
Scientists say a study that sequenced human cancers found far less microbial DNA sequences than earlier studies reported in the same cancer tissue samples.
-
NewsConnection among gut fungi, genetics and disease risk in humans identified
A novel genome-wide association study sheds light on the human genetic determinants of the fungal component of the human microbiome and their relation to chronic disease.
-
NewsFighting extinction, coral reefs show signs of adapting to warming seas
By studying how six months of elevated ocean temperatures would affect a species of coral from the northern Red Sea, scientists found that although these organisms can certainly survive in conditions that mimic future warming trends, they don’t thrive.
-
NewsBroccoli seeds can spread resistance to multiple fungicides
Researchers who screened commercial broccoli seeds for Alternaria brassicicola, a fungal pathogen, found that seeds can harbor A. brassicicola and can spread resistance to multiple fungicides. Based on the findings, the researchers developed a faster way for detecting and monitoring fungicide resistance.
-
NewsGray seals perplex scientists with lack of response to flu infection
Something strange happens when two kinds of seals living in the waters around Cape Cod get infected with influenza – harbor seals get sick but gray seals don’t. This perplexing phenomenon led scientists to investigate if a difference in a piece of the immune system called cytokines could be responsible for this difference.
-
NewsProtein discovery gives new hope for longer COVID protection
Scientists have discovered that the body’s immune system strongly reacts to an internal protein from SARS-CoV-2, the virus that causes COVID-19, which mutates less frequently than the surface-spike protein currently targeted by vaccines.
-
NewsAre probiotics worth the cost to prevent infection after a colon removal surgery?
A study found that taking an 8-strain probiotic daily may reduce the risk of pouchitis, a common inflammatory condition that occurs after colon removal surgery for ulcerative colitis, but the treatment may not be worth the cost depending on a patient’s likelihood of flare-ups.
-
NewsNew papers reveal how gut-brain interactions shape eating behaviors
Researchers found that stress from life circumstances can disrupt the brain-gut-microbiome balance. This disruption may alter mood, decision-making, and hunger signals — increasing the likelihood of craving and consuming high-calorie foods.
-
NewsPretreatment methods deploying microbes bring second-gen biofuels from oilcane closer to commercialization
In collaboration with other Bioenergy Research Centers (BRCs), researchers at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) are developing industrially feasible techniques for second-generation biofuel production from oilcane, an oil-rich variety of sugarcane, to help meet our growing societal demand for fuels. Source: April Wendling/CABBI CABBI ...
-
NewsAntibody-making cells reveal new function in response to flu infection
A study has uncovered a new function of the immune cells that are known for making antibodies. Researchers determined that, in response to flu infection, a specialized set of B cells produce a key signaling molecule that the immune system needs to develop a robust, long-term response to fight off infections.
-
NewsOne dose of antibiotic treats early syphilis as well as three doses
Researchers have found that a single injection of the antibiotic benzathine penicillin G (BPG) successfully treated early syphilis just as well as the three-injection regimen used by many clinicians. These findings from a late-stage clinical trial suggest the second and third doses of conventional BPG therapy do not provide a health benefit.
-
NewsThe cling of doom: How staph bacteria latch onto human skin
Scientists have discovered the strongest natural protein bond ever recorded, explaining how Staphylococcus aureus clings so tightly to human skin and pointing to new ways to fight antibiotic resistance.